• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

Identification of molecular mechanisms regulating IFN responses in the novel susceptible gene of Bechet's disease, TRIM39R.

Research Project

Project/Area Number 16K21229
Research Category

Grant-in-Aid for Young Scientists (B)

Allocation TypeMulti-year Fund
Research Field Collagenous pathology/Allergology
Immunology
Research InstitutionOsaka University of Pharmaceutical Sciences (2018-2019)
Saga University (2016-2017)

Principal Investigator

Kurata Riho  大阪薬科大学, 薬学部, 助教 (70711729)

Project Period (FY) 2016-04-01 – 2020-03-31
Project Status Completed (Fiscal Year 2019)
Budget Amount *help
¥4,160,000 (Direct Cost: ¥3,200,000、Indirect Cost: ¥960,000)
Fiscal Year 2018: ¥1,430,000 (Direct Cost: ¥1,100,000、Indirect Cost: ¥330,000)
Fiscal Year 2017: ¥1,300,000 (Direct Cost: ¥1,000,000、Indirect Cost: ¥300,000)
Fiscal Year 2016: ¥1,430,000 (Direct Cost: ¥1,100,000、Indirect Cost: ¥330,000)
Keywords自然免疫 / 炎症 / 自己免疫疾患 / ベーチェット病 / TRIM / インターフェロン / サイトカイン / インターロイキン / 遺伝子欠損マウス / 遺伝子導入マウス / 炎症応答 / tripartite motif protein / 炎症性疾患 / 免疫学
Outline of Final Research Achievements

Three proteins, TRIM39, TRIM39R, and RPP21, are generated from genes in the susceptible genetic region of Bechet's disease. Among these, only TRIM39R was shown to induce NF-kB and IRF by overexpression. Although TRIM39 and TRIM39R have relative similar three-dimensional structures, but the difference of the C-terminal domain in homodimers was showed by three-dimensional structural analysis. Furthermore, we succeeded in establishing TRIM39R-deficient and human TRIM39R transgenic mice. We are going to continue to analyze molecular mechanism of TRIM39R using various approaches such as, in silico, in vitro and in vivo.

Academic Significance and Societal Importance of the Research Achievements

本研究において、ベーチェット病(BD)感受性遺伝子として同定したTRIM39Rが炎症性サイトカイン産生およびⅠ型IFN応答を制御することを明らかにした。TRIM39RはBDだけでなく、全身性エリテマトーデスや炎症性腸疾患および乾癬などとの関連も報告されている。また炎症性サイトカイン産生およびⅠ型IFN応答はウイルス感染防御に重要で、TRIM39はウイルス感染後の炎症応答を開始させる重要な分子の1つである可能性が考えられる。今後TRIM39Rの炎症応答における機能解析を進めることで、炎症を伴う様々な感染症や疾患の病態解明に貢献できる。

Report

(5 results)
  • 2019 Annual Research Report   Final Research Report ( PDF )
  • 2018 Research-status Report
  • 2017 Research-status Report
  • 2016 Research-status Report
  • Research Products

    (13 results)

All 2020 2019 2018 Other

All Int'l Joint Research (1 results) Journal Article (8 results) (of which Int'l Joint Research: 4 results,  Peer Reviewed: 8 results,  Open Access: 4 results) Presentation (4 results)

  • [Int'l Joint Research] Wuhan University of Technology(中国)

    • Related Report
      2018 Research-status Report
  • [Journal Article] Novel Reporter System Monitoring IL-18 Specific Signaling Can Be Applied to High-Throughput Screening2020

    • Author(s)
      Kurata R, Shimizu K, Cui X, Harada M, Isagawa T, Semba H, Ishihara J, Yamada K, Nagai J, Yoshida Y, Takeda N, Maemura K, Yonezawa T.
    • Journal Title

      Marine Drugs

      Volume: 18 Issue: 1 Pages: 60-60

    • DOI

      10.3390/md18010060

    • NAID

      120006988310

    • Related Report
      2019 Annual Research Report
    • Peer Reviewed / Open Access / Int'l Joint Research
  • [Journal Article] Establishment of Novel High-Standard Chemiluminescent Assay for NTPase in Two Protozoans and Its High-Throughput Screening2020

    • Author(s)
      Masamitsu Harada, Jun Nagai, Riho Kurata, Kenji Shimizu, Xiaofeng Cui, Takayuki Isagawa, Hiroaki Semba, Jun Ishihara, Yasuhiro Yoshida, Norihiko Takeda, Koji Maemura, Tomo Yonezawa
    • Journal Title

      Marine Drugs

      Volume: 18 Issue: 3 Pages: 161-161

    • DOI

      10.3390/md18030161

    • NAID

      120006988256

    • Related Report
      2019 Annual Research Report
    • Peer Reviewed / Open Access / Int'l Joint Research
  • [Journal Article] Establishment of novel cells stably secreting various human IL-18 recombinant proteins.2019

    • Author(s)
      Asuka Kumagai, Kenji Shimizu, Riho Kurata, Xiaofeng Cui, Takayuki Isagawa, Msamitsu Harada, Jun Nagai, Yasuhiro Yoshida, Kei-ichi Ozaki, Norihiko Takeda, Hiroaki Semba and Tomo Yonezawa
    • Journal Title

      Current Pharmaceutical Biotechnology

      Volume: 20 Issue: 1 Pages: 47-55

    • DOI

      10.2174/1389201020666190206203640

    • Related Report
      2019 Annual Research Report 2018 Research-status Report
    • Peer Reviewed / Open Access / Int'l Joint Research
  • [Journal Article] 多発性硬化症等の自己免疫疾患治療薬作出のための化合物スクリーニング2019

    • Author(s)
      倉田里穂 , 熊谷飛鳥 , 尾崎惠一 , 米澤朋
    • Journal Title

      Bio Clinica

      Volume: 34 Pages: 532-535

    • Related Report
      2019 Annual Research Report
    • Peer Reviewed
  • [Journal Article] ヒト γδT 細胞抗腫瘍活性を用いた新規免疫細胞治療のための創薬研究2019

    • Author(s)
      熊谷 飛鳥 , 倉田 里穂 , 尾崎 惠一 , 砂河 孝行 , 仙波 宏章 , 武田 憲彦 , 前村 浩二 , 米澤 朋
    • Journal Title

      BIO Clinica

      Volume: 34 Pages: 77-81

    • Related Report
      2019 Annual Research Report
    • Peer Reviewed
  • [Journal Article] 新規ベーチェット病感受性遺伝子TRIM39Rおよび I型IFN応答2019

    • Author(s)
      倉田里穂 , 米澤 朋 , 尾﨑 惠一 , 猪子 英俊
    • Journal Title

      アレルギーの臨床

      Volume: 39 Pages: 47-52

    • Related Report
      2019 Annual Research Report
    • Peer Reviewed
  • [Journal Article] 多発性硬化症等の自己免疫疾患治療薬作出のための化合物スクリーニング.2019

    • Author(s)
      倉田 里穂, 熊谷 飛鳥, 尾﨑 惠一, 米澤 朋.
    • Journal Title

      BIO Clinica.

      Volume: 34 Pages: 52-55

    • Related Report
      2018 Research-status Report
    • Peer Reviewed
  • [Journal Article] Establishment of Novel Reporter Cells Stably Maintaining Transcription Factor-driven Human Secreted Alkaline Phosphatase Expression.2018

    • Author(s)
      Riho Kurata, Asuka Kumagai, Xiaofeng Cui, Masamitsu Harada, Jun Nagai, Yasuhiro Yoshida, Kei-ichi Ozaki, Yoshimasa Tanaka and Tomo Yonezawa.
    • Journal Title

      Curr Pharm Biotechnol.

      Volume: 19 Issue: 3 Pages: 224-231

    • DOI

      10.2174/1389201019666180418093334

    • NAID

      120006987932

    • Related Report
      2018 Research-status Report
    • Peer Reviewed / Open Access / Int'l Joint Research
  • [Presentation] ERK1/2-MAPK下流キナーゼMnk1/2のがん分子標的としての可能性2019

    • Author(s)
      倉田里穂, 福永理己郎, 尾﨑惠一
    • Organizer
      日本がん分子標的治療学会
    • Related Report
      2019 Annual Research Report
  • [Presentation] 大気汚染物質を評価するための分泌型アルカリフォスファターゼを用いたリポーター細胞の樹立2019

    • Author(s)
      米澤 朋 , 倉田 里穂 , 熊谷 飛鳥 , 尾崎 惠一 , 吉田 安宏
    • Organizer
      日本分子生物学会
    • Related Report
      2019 Annual Research Report
  • [Presentation] ヒト分泌型アルカリホスファターゼ発現を安定に維持する新規レポーター細胞の樹立.2018

    • Author(s)
      倉田 里穂, 熊谷 飛鳥, Xiaofeng Cui, 原田 将光, 永井 潤, 吉田 安宏, 尾﨑 惠一, 米澤 朋.
    • Organizer
      第41回分子生物学会年会
    • Related Report
      2018 Research-status Report
  • [Presentation] 多様なヒトIL18組換えタンパク質を安定に分泌する新規細胞の樹立.2018

    • Author(s)
      熊谷 飛鳥, 清水 謙次, 倉田 里穂, Xiaofeng Cui, 砂河 孝行, 原田 政光, 永井 潤, 吉田 安宏, 尾﨑 惠一, 米澤 朋.
    • Organizer
      第41回分子生物学会年会
    • Related Report
      2018 Research-status Report

URL: 

Published: 2016-04-21   Modified: 2021-02-19  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi